A Trial of Transplanting Hepatitis C-viremic Kidneys into Hepatitis C-Negative Kidney Recipients (THINKER-NEXT)

May 2024 Council

Lead Division/Office

KUH

Point(s) of Contact

Susan Mendley, M.D.; Kevin Abbott, M.D., M.P.H.

Executive Summary

THINKER NEXT is an ongoing multi-center trial with an overarching goal to determine if kidneys from HCV-viremic donors can safely be transplanted into HCV negative patients with end-stage renal disease. Enrollment of trial participants, kidney transplantation, and one year follow-up of the cohort is anticipated to occur at the end of the current funding period. This initiative proposes an additional one year of funding to complete analysis of the data from the THINKER NEXT trial.